A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: Implications for clinical interpretation

PLoS Medicine

Volumn 7, Issue 9, 2010, Pages

  Rhodes, Benjamin ^a   Merriman, Marilyn E ^b   Harrison, Andrew ^c   Nissen, Michael J ^d   Smith, Malcolm ^d   Stamp, Lisa ^e   Steer, Sophia ^f   Merriman, Tony R ^b   Vyse, Timothy J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d REPATRIATION GENERAL HOSPITAL   (Australia)

^e UNIVERSITY OF OTAGO   (New Zealand)

^f KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ACCURACY; ACUTE PHASE RESPONSE; ADULT; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; GENETICS; METABOLISM;

ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77957872865     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000341     Document Type: Article

References (37)

1. Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, et al. (2005) Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 77: 64-77.
2. Miller DT, Zee RY, Suk DJ, Kozlowski P, Chasman DI, et al. (2005) Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69: 623-638.
3. Crawford DC, Sanders CL, Qin X, Smith JD, Shephard C, et al. (2006) Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 114: 2458-2465.
4. Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, et al. (2006) Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 113: 1415-1423.
5. Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, et al. (2006) Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 296: 2703-2711.
6. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, et al. (2004) Creactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350: 1387-1397.
7. Danesh J, Pepys MB (2009) C-reactive protein and coronary disease: is there a causal link? Circulation 120: 2036-2039.
8. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111: 1805-1812.
9. D'Aiuto F, Casas JP, Shah T, Humphries SE, Hingorani AD, et al. (2005) Creactive protein (+1444C.T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 179: 413-417.
10. Motoyama S, Miura M, Hinai Y, Maruyama K, Usami S, et al. (2009) Creactive protein 1059G.C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer. J Am Coll Surg 209: 477-483.
11. Perry TE, Muehlschlegel JD, Liu KY, Fox AA, Collard CD, et al. (2009) CReactive protein gene variants are associated with postoperative C-reactive protein levels after coronary artery bypass surgery. BMC Med Genet 10: 38.
12. Suk DJ, Chasman DI, Cannon CP, Miller DT, Zee RY, et al. (2006) Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Ann Hum Genet 70: 705-716.
13. Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, et al. (2003) Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23: 2063-2069.
14. Ropes MW, Rossmeisl E, Bauer W (1939) The relationship between the erythrocyte sedimentation rate and the plasma proteins. J Clin Invest 18: 791-798.
15. Zlonis M (1993) The mystique of the erythrocyte sedimentation rate. A reappraisal of one of the oldest laboratory tests still in use. Clin Lab Med 13: 787-800.
16. Andersson R, Malmvall BE, Bengtsson BA (1986) Acute phase reactants in the initial phase of giant cell arteritis. Acta Med Scand 220: 365-367.
17. Osei-Bimpong A, Meek JH, Lewis SM (2007) ESR or CRP? A comparison of their clinical utility. Hematology 12: 353-357.
18. Steer S, Lad B, Grumley JA, Kingsley GH, Fisher SA (2005) Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset/disease severity effect. Arthritis Rheum 52: 358-360.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
20. Rhodes B, Meek J, Whittaker JC, Vyse TJ (2008) Quantification of the genetic component of basal C-reactive protein expression in SLE nuclear families. Ann Hum Genet 72: 611-620.
21. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
22. Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73: 1162-1169.
23. Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, et al. (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440: 1217-1221.
24. Ridker PM, Pare G, Parker A, Zee RY, Danik JS, et al. (2008) Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 82: 1185-1192.
25. Verzilli C, Shah T, Casas JP, Chapman J, Sandhu M, et al. (2008) Bayesian meta-analysis of genetic association studies with different sets of markers. Am J Hum Genet 82: 859-872.
26. Kushner I, Samols D, Magrey M (2010) A unifying biologic explanation for ''high-sensitivity'' C-reactive protein and ''low-grade'' inflammation. Arthritis Care Res (Hoboken) 62: 442-446.
27. Fransen J, Welsing PM, de Kuijzer RM, van Riel PL (2004) Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 62 (Suppl 1): 151.
28. Artz AS, Wickrema A, Dinner S, Godley LA, Kocherginsky M, et al. (2008) Pretreatment C-reactive protein is a predictor for outcomes after reducedintensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 14: 1209-1216.
29. Bajwa EK, Khan UA, Januzzi JL, Gong MN, Thompson BT, et al. (2009) Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest 136: 471-480.
30. Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, et al. (2009) Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 9: 155.
31. Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, et al. (2008) Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol 98: 540-544.
32. Kompoti M, Drimis S, Papadaki A, Kotsomytis K, Poulopoulou C, et al. (2008) Serum C-reactive protein at admission predicts in-hospital mortality in medical patients. Eur J Intern Med 19: 261-265.
33. Moon JM, Chun BJ (2009) Predicting the complicated neutropenic fever in the emergency department. Emerg Med J 26: 802-806.
34. Poole CD, Conway P, Reynolds A, Currie CJ (2008) The association between Creactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study. BMC Musculoskelet Disord 9: 146.
35. van der Helm-van Mil A, le CS, van DH, Breedveld FC, Toes RE, et al. (2007) A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 56: 433-440.
36. Rhodes B, Wong A, Navarra SV, Villamin C, Vyse TJ (2008) Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families. Genes Immun 9: 153-160.
37. Rhodes B, Morris DL, Subrahmanyan L, Aubin C, de Leon CF, et al. (2008) Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach. Hum Genet 123: 633-642.